Table 5.
Compound | Microalgae | Bioactivity | Concentration | Ref. |
---|---|---|---|---|
Amphidinols 1, 2, 4, 5 and 6 (AM1, AM2, AM4, AM5, AM6) | Amphidinium klebsii | Antifungal activity against Aspergillus niger Haemolytic activity on human erythrocytes |
In vitro disk assay: Minimum effect concentration (MEC) value 4 to 6 µg/disk In vitro Half maximum effective concentrations (EC50 values): 50 nM (AM1) 910 nM (AM2) 185 nM (AM4) 230 nM (AM5) 580 nM (AM6) |
[204] |
Amphidinol 2 (AM2) | Amphidinium klebsii | Anticancer activity against colon cancer cells HCT116, HT29, and breast cancer cells MCF7 | Half maximal inhibitory concentration (IC50) values: 6.18 µM (HCT116) 0.87 µM (HT29) 2.98 µM (MCF7) |
[205] |
Amphidinol 3 (AM3) | Amphidinium klebsii | Antifungal activity against Aspergillus niger Haemolytic activity on human erythrocytes |
In vitro disk assay: MEC value 9 µg/disk In vitro EC50 value: 250 nM |
[206] |
Amphidinol 7 (AM7) | Amphidinium klebsii | Antifungal activity against Aspergillus niger Haemolytic activity on human erythrocytes |
In vitro disk assay: MEC value 10 µg/disk In vitro EC50 value: 300 nM |
[207] |
Amphidinol 9 (AM9) | Amphidinium carterae | Antifungal activity against Aspergillus niger Haemolytic activity on human erythrocytes |
In vitro disk assay: MEC value 10 µg/disk In vitro EC50 value: 300 nM |
[200] |
Amphidinols 10, 11, 12 and 13 (AM10, AM11, AM12 and AM13) | Amphidinium carterae | Antifungal activity against Aspergillus niger Haemolytic activity on human erythrocytes |
In vitro disk assay: MEC value >100 µg/disk In vitro EC50 value: >2000 nM |
[200] |
Amphidinols 14 and 15 (AM14 and AM15) | Amphidinium klebsii | Antifungal activity against Aspergillus niger Haemolytic activity on human erythrocytes |
In vitro disk assay: MEC value >60 µg/disk In vitro EC50 value: >50 µM |
[199] |
Amphidinol 17 (AM17) | Amphidinium carterae | Antifungal activity against Aspergillus niger, and Candida kefyr. Haemolytic activity on human erythrocytes |
In vitro disk assay: not detectable antifungal activity In vitro EC50 value: >4.5 µM |
[208] |
Amphidinols 18 and 19 (AM18 and AM19) | Amphidinium carterae | Antifungal activity against Candida albicans | In vitro growth inhibition assay: MIC values 9 µg/mL (AM18) Not detectable activity (AM19) |
[201] |
Amphidinols 20 and 21 (AM20 and AM21) | Amphidinium carterae | Antifungal activity against Aspergillus niger Haemolytic activity on human erythrocytes |
In vitro disk assay: MEC value >15 µg/disk In vitro EC50 value: 1–3 µM (AM20) >10 µM (AM21) |
[202] |
Amphidinol 22 (AM22) | Amphidinium carterae | Antifugal activity against Candida albicans and Aspergillus fumigatus Anticancer activity against several cancer cell lines |
Minimum inhibitory concentration value (MIC): 64 µg/mL In vitro: Half maximal inhibitory concentration (IC50) values: from 6 to 16 µM |
[203] |
Amphidinols A and B (AM-A and AM-B) | Amphidinium carterae | Antifungal activity against Candida albicans | In vitro growth inhibition assay: MIC values 19 µg/mL (AM-A) >150 µg/mL (AM-B) |
[209] |
Karantungiol A | Amphidinium sp. | Antifungal activity against NBRC4407 Aspergillus niger Antiprotozoal activity against Trichomonas foetus |
In vitro disk assay: 12 µg/disc In vitro Antiprotozoal assay: MIC 1 µg/mL |
[210] |
Amphidinolides H and N (AMP-H and AMP-N) | Amphidinium sp. | Anticancer activity against L1210 murine leukemia cells and KB human epidermoid carcinoma cells | Half maximal inhibitory concentration (IC50) values: 0.48 ng/mL (AMP-H, L1210) 0.52 ng/mL (AMP-H, KB) 0.05 ng/mL (AMP-N, L1210) 0.06 ng/mL (AMP-N, KB) |
[211] |
Amphirionin 2 | Amphidinium sp. | Anticancer activity against colon cancer Caco-2 and lung cancer A549 cells | Half maximal inhibitory concentration (IC50) values: 100 ng/mL (Caco-2) 600 ng/mL (A549) |
[212] |
Gambieric acids A and B | Gambierdiscus toxicus | Antifungal activity against several fungal strains | In vitro growth inhibition assay: MIC values 0.2 to 6.25 µg/mL depending on compound/strain |
[213] |
Goniodomin A | Goniodoma pseudogoniaulax | Antifungal activity against Mortierella ramannianus and Candida albicans Reduction on metabolic rate of BE(2)-M17 human neuroblastoma cells |
Growth inhibition at a concentration of 0.5 µg/mL In vitro: 50% decreased metabolic rate after 6-h incubation with 15 μM |
[214,215] |